Barry Clements

Brandon Capital Partners Pty Ltd. (Brandon Capital Partners) is a venture capital firm founded in 2007 by David Fisher and Chris Nave. The firm is headquartered in Sydney, Australia.

OncoRes Medical Pty Ltd. develops an imaging medical device which provides micro-scale images of tissue stiffness and elasticity information to surgeons. The company is headquartered in Nedlands, Australia.

Microsize LLC specializes in enhancing the dissolution and bioavailability of APIs through particle size reduction using micronization technologies. The company is based in Quakertown, PA. The company is the largest independent US-based company specializing in micronization and particle size control. The company has expertise in developing milling and micronization processes for a diverse range of API and excipient materials with unique physical property challenges. The company was founded in 1994. The CEO is TJ Higley.

Matteo Mining Corp. Pty Ltd. provides support services for companies engaged in underground mining and tunneling system. The company is headquartered in Balcatta, Australia.

Dimerix Bioscience Pty Ltd. engages in the development and commercialization of drug therapies and drug discovery tools. It deals with clinical research organizations to progress its programs through clinical studies. It focuses on the clinical development of its therapeutic product DMX200 which is targeted to treat patients with chronic kidney disease. The company was founded by James Howard Williams on December 16, 2004 and is headquartered in Melbourne, Australia.

Nemgenix Pty Ltd. develops new technologies for the control of plant parasitic nematodes and aphids. The company was founded by Sean Hird and Michael Jones in 2007 and is headquartered in Perth, Australia.

Stone Ridge Ventures Pty Ltd (Stone Ridge Ventures) is a venture capital firm founded in 2002 by Matthew Callahan and Robert Melville Newman. The firm is headquartered in Balcatta, Australia.

Riverside Partners LLC /New York/ (Riverside Partners) is a private equity firm founded in 1988 by Bela Szigethy. The firm is headquartered in Boston, Massachusetts with additional offices across the globe.

Botanix Pharmaceuticals, Inc. develops therapeutics for the treatment of serious skin diseases. Its products include BTX1503-Acne, BTX1308-Plaque Psoriasis, and BTX1204-Atopic Dermatitis. The company is headquartered in Plymouth Meeting, PA.

Glycan Bioscience LLC develops carbohydrate-based drugs. The private company is based in New York. The American company was founded by Zoltan Kerekes.

Ben Franklin Technology Partners of Southeastern Pennsylvania engages in investment and advisory services. It provides capital to information technology, health, manufacturing, energy, and physical sciences industries. The company is headquartered in Philadelphia, PA.

The Cash Store Australia Holdings, Inc. is engages in the provision of brokerage services. It also offers other financial products & services such as payday loan. It operates its business under its brand name "The Cash Store." The company was founded on March 6, 2009 and is headquartered in Edmonton, Canada.

Elastagen Pty Ltd. produces and develops synthetic human elastin for medical device applications. Its products include skin rejuvenation, scar remodeling, skin tissue repair, wound healing, surgical glues and sealants. The firm developed a Elastatherapy treatments which offer the chance to restore the levels of Elastin in human skin, with benefits anticipated in both medical dermatology and cosmetic applications. The company was founded by Anthony Weiss in 2003 and is headquartered in Sydney, Australia.

MiReven Pty Ltd. operates as an Australian biopharmaceutical company. The private company is based in Nedlands, Australia.

Vaxxas Pty Ltd. develops and commercializes needle-free vaccine delivery system solutions. Its flagship products, Nanopatch, consists of an array of thousands of vaccine coated microprojections that perforate into the outer layers of the skin when applied with an applicator device. The tips of Nanopatch's microprojections are coated with a vaccine material and release this material directly to the large numbers of key immune cells immediately below the skin surface. The company was founded by Mark Kendall in August 2011 and is headquartered in Sydney, Australia.

Apax Partners LLP engages in providing investment services. It focuses on investing in firms across the global sectors such as technology and telecommunications, services, healthcare, and consumer. The company was founded by Ronald Mourad Cohen and Alan J. Patricof in 1969 and is headquartered in London, the United Kingdom.

Cancer Therapeutics CRC Pty Ltd. engages in research and development novel oncology drug and clinical diseases. It focuses in recombinant protein production, structural biology, DMPK, and translational cancer biology. The company was founded in 2007 and is headquartered in Melbourne, Australia.

AusBiotech Ltd. operates as an Australian biotechnology membership company. The private company is based in Melbourne, Australia. and has subsidiaries in Australia. The company was founded by Liz Dallimore. Lorraine Chiroiu has been the CEO of the company since 2008.

Longas Technologies Pty Ltd. is engaged in developing next generation sequencing (NGS) technologies. The company was founded by Ian Charles, Aaron Darling, and Catherine Burke in 2015 and is headquartered in Sydney, Australia.

MecRx Pty Ltd. develops drugs for treatment of cancer. The company was founded by Ian Holmes, Jo Alcindor, Tom Peat and Janet Newman in 2013 and is headquartered in Melbourne, Australia.

Myricx Pharma Ltd. engages in the development of novel proprietary inhibitors of human N-myristoyltransferases. The company was founded by Ed Tate, Roberto Solari, and Andrew Bell in 2019 and is headquartered in Stevenage, the United Kingdom.

Intellection Pty Ltd. develops integrated solutions for automated, quantitative evolution of minerals, rocks and man-made materials. The company is headquartered in Milton, Australia.

iCeutica, Inc. manufactures pharmaceutical products. It offers SoluMatrix platform, a drug reformulation and delivery technology for poorly water-soluble compounds. This technology enables iCeutica to make significantly improved formulations of approved and development stage drugs, some of which have been shown in late stage clinical trials to work faster, at a lower dose or be delivered to the body by an alternative route. The company was founded by James Williams and Matthew Callahan in 2005 and is headquartered in Philadelphia, PA.